Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05903885 · ClinicalTrials.gov registry record · NA
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
A NA study of Colorectal Cancer and Prevention, sponsored by University of Nebraska.
- Recruiting
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
- 2
- Study locations
NCT05903885: Recruiting NA study of Colorectal Cancer and Prevention, sponsored by University of Nebraska.
NCT05903885 is a NA study of Colorectal Cancer and Prevention that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 1,200 participants, below the 1,542-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (22% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05903885, a NA study of Colorectal Cancer and Prevention, is actively recruiting participants, sponsored by University of Nebraska.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
- 2
- Study locations
Study Summary
African Americans face racial disparities in colorectal cancer (CRC), with lower screening rates and higher incidence and mortality rates. To address this gap and improve CRC screening rates, investigators aims to recruit a total of 1,200 African American participants aged 45-75 during their visits to the DMV, 4606 N 56th St Ste100, Omaha, for CRC screening. All participants will receive a free Fecal Immunochemical Test (FIT) kit with a prepaid return envelope, a culturally tailored educational brochure, reminder text messages and calls, and post-FIT navigation support for participants with positive results or without family doctor/insurance. Kits are returned to a designated Nebraska Medicine lab for testing, and test results will be mailed to participants within 14-21 days. Participants will be assigned to one of two groups: the on-site distribution group or the on-site distribution group with social media advertising group. The social media advertising group will additionally be exposed to targeted ads on platforms like Facebook, Instagram, and YouTube to increase awareness and potentially improve participation rates. The study will compare FIT kit return rates, positive screening rates, and completion rates of follow-up colonoscopies after positive FIT results between the two groups.
Primary Outcome
The fecal immunochemical test kit (FIT) return rate is the proportion of participants who have completed the screening by returning the FIT kits.
Conditions Studied
Interventions
- OTHER On-site Fecal Immunochemical Test (FIT) Kit Distribution
- OTHER On-site With Social Media Advertising Fecal Immunochemical Test (FIT) Kit Distribution
Study Locations (2)
Nebraska
- Department of Motor Vehicles (DMV) - Omaha
- Douglas County Treasurer's Office - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT05903885 shows while recruiting
NCT05903885 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, below the 1,542-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (22% lower).
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which On-site Fecal Immunochemical Test (FIT) Kit Distribution is the first listed.
NCT05903885 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT05903885 about?
NCT05903885 is a clinical study titled "A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans". African Americans face racial disparities in colorectal cancer (CRC), with lower screening rates and higher incidence and mortality rates. To address this gap and improve CRC screening rates, investigators aims to recruit a total of 1,200 African American participants aged 45-75 during their visits ...
What is the current status of trial NCT05903885?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2023-10-02. Estimated completion is 2026-10.
What conditions does trial NCT05903885 study?
This clinical trial studies the following conditions: Colorectal Cancer, Prevention.
What interventions are being tested in trial NCT05903885?
The interventions under investigation include: On-site Fecal Immunochemical Test (FIT) Kit Distribution (OTHER), On-site With Social Media Advertising Fecal Immunochemical Test (FIT) Kit Distribution (OTHER).
Who is sponsoring clinical trial NCT05903885?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05903885 being conducted?
This trial has 2 study locations across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05903885's enrollment target sits among peer trials
1,200 41st of 381 higher than 340 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
-
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI